Comparison 5. Incidence of multiple end points (death or myocardial infarction) over all time periods.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
5.1 Heparin vs placebo or untreated control | 8 | 3110 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.61 [0.47, 0.80] |
5.1.1 LMWH | 2 | 1602 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.34 [0.18, 0.61] |
5.1.2 UFH | 5 | 1225 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.80 [0.58, 1.08] |
5.1.3 UFH + warfarin | 2 | 283 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.43 [0.15, 1.28] |